AstraZeneca

Life sciences investment company Malin said on Monday that its investee company Poseida Therapeutics has filed for a potential initial public offering(...)

European shares lost further ground in their first trading day of 2019 on Wednesday as fears about global growth, trade wars and political instability(...)

Ireland’s stock market benchmark, the Iseq, joined a raft of European indices in a rally yesterday to end a volatile shortened week of trading that h(...)

European shares edged up on Friday, buoyed by a bounce on Wall Street as a turbulent week drew to a close and investors licked their wounds. The Sto(...)

The Euro Stoxx 50 index sank 1.2 per cent on Thursday, entering a bear market, as European equities failed to sustain optimism from the Wednesday rall(...)

GlaxoSmithKline has agreed to buy US cancer specialist Tesaro for $5.1 billion (€4.5 billion), marking a major biotech investment by chief executive E(...)

Dr Elaine Sullivan, co-founder and chief executive of early-stage life-sciences company Carrick Therapeutics, has been chosen as The Irish Times Busin(...)

European shares made only modest gains on Thursday as a global rally that followed the US midterm elections faded, although strong results from a numb(...)

Strong demand for AstraZeneca’s new drugs – especially those for cancer – drove a return to sales growth in the third quarter and the drugmaker said i(...)

European shares ended in positive territory, breaking a six-day losing streak, after a tentative recovery was lent support in the afternoon by a rally(...)